Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,112B 11.68B 10.48B 9.69B 8.78B 16.39B 16.59B 116B 46.14B 582B 43.83B 42.91B 1,848B P/E 2027 *
29.9x
P/E 2028 * 22.8x
Enterprise Value 1,082B 11.36B 10.19B 9.42B 8.54B 15.95B 16.14B 113B 44.88B 566B 42.64B 41.74B 1,798B EV / Sales 2027 *
3.08x
EV / Sales 2028 * 2.7x
Free-Float
69.73%
Yield 2027 *
0.56%
Yield 2028 * 0.63%
1 day+2.33%
1 week+7.52%
Current month+8.04%
1 month+11.02%
3 months+16.03%
6 months+0.06%
Current year+5.06%
1 week 1,213.05
Extreme 1213.05
1,338
1 month 1,166.75
Extreme 1166.75
1,338
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 12/05/2014
Chairman 65 01/04/2013
Director/Board Member 65 24/10/2018
Date Insider Type Main position Quantity % Market Cap. Importance
01/04/26 Other

Global Head of Quality and PV

35,600 0.0043% -
18/12/25 Other

Chairman

85,738,125 10.2732%
18/12/25 Other

Director

12,717,090 1.5238%
Change 5-day change 1-year change 3-year change Capi.($)
+2.33%+7.52%+3.95%+23.98% 11.45B
+0.50%+0.36%+55.89%+129.96% 1,143B
+0.86%+4.50%+42.43%+86.15% 647B
-0.14%-1.07%+25.42%+105.85% 506B
-0.05%+2.28%+49.14%+67.74% 384B
-0.63%-4.97%+60.15%+37.06% 350B
+0.34%+2.15%+25.26%+54.27% 293B
-0.45%+1.16%+1.74%+26.08% 265B
+0.87%+3.08%+54.69%+71.67% 242B
+0.08%+3.67%+35.05%+104.71% 197B
Average +0.68%+1.14%+35.37%+70.75% 403.9B
Weighted average by Cap. +0.70%+0.36%+42.63%+88.62%

Financials

2027 *2028 *
Net sales 351B 3.69B 3.31B 3.06B 2.77B 5.18B 5.24B 36.59B 14.57B 184B 13.84B 13.55B 584B 394B 4.13B 3.71B 3.43B 3.11B 5.8B 5.87B 41B 16.33B 206B 15.51B 15.19B 654B
Net income 36.92B 388M 348M 322M 291M 544M 551M 3.84B 1.53B 19.32B 1.45B 1.42B 61.34B 49.29B 517M 464M 429M 389M 726M 735M 5.13B 2.04B 25.79B 1.94B 1.9B 81.87B
Net Debt -30.34B -319M -286M -264M -239M -447M -453M -3.16B -1.26B -15.88B -1.2B -1.17B -50.41B -49.26B -517M -464M -429M -389M -726M -735M -5.13B -2.04B -25.77B -1.94B -1.9B -81.82B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
28/10/26 ₹1,335.40 +2.33% 49,295
27/10/26 ₹1,305.00 +0.15% 72,496
26/10/26 ₹1,303.00 +6.41% 469,080
23/10/26 ₹1,224.50 -1.17% 306,106
22/10/26 ₹1,239.00 +0.11% 30,293
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,335.40INR
Average target price
1,358.95INR
Spread / Average Target
+1.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DRREDDY Stock